CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Humans Have Kept Evolving New Genes

Humans Have Kept Evolving New Genes

The Necessity of Next-Generation Sequencing

The Necessity of Next-Generation...

The Next-Generation Sequencing Revolution Revitalizes Clinical Metagenomics

The Next-Generation Sequencing...

Technologies to have an impact on science this year.

Technologies to have an impact on...

A rise in DNA Sequencing Market is expected in coming years

A rise in DNA Sequencing Market is...

Portuguese Start-Up Kicks Off Genetic Test That Detects Diseases In Babies Using Saliva

Portuguese Start-Up Kicks Off Genetic...

Element Biosciences Strikes Multiple Partnerships to Integrate Sequencer With Existing NGS Products

Element Biosciences Strikes Multiple...

Technologies that will revolutionize cancer care

Technologies that will revolutionize...

Humans Have Kept Evolving New Genes

Humans Have Kept Evolving New Genes

The Necessity of Next-Generation Sequencing

The Necessity of Next-Generation...

The Next-Generation Sequencing Revolution Revitalizes Clinical Metagenomics

The Next-Generation Sequencing...

Technologies to have an impact on science this year.

Technologies to have an impact on...

A rise in DNA Sequencing Market is expected in coming years

A rise in DNA Sequencing Market is...

Portuguese Start-Up Kicks Off Genetic Test That Detects Diseases In Babies Using Saliva

Portuguese Start-Up Kicks Off Genetic...

Element Biosciences Strikes Multiple Partnerships to Integrate Sequencer With Existing NGS Products

Element Biosciences Strikes Multiple...

Technologies that will revolutionize cancer care

Technologies that will revolutionize...

Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Life Sciences Review | Wednesday, June 08, 2022
Tweet

Global Next Generation Sequencing (NGS) Data Analysis Market to Reach US$1.2 Billion by the Year 2026


FREMONT, CA: The widespread adoption of the technology for analyzing RNA and DNA sequences is expected to fuel growth in the global market. Cloud-based  platforms are quickly becoming popular for executing computationally intensive operations during NGS data analysis because they make it quick and easy for researchers to obtain computational resources for large-scale NGS data analysis. Recent advances in cloud computing and bioinformatics have resulted in the creation of a diverse set of cloud-based bioinformatics platforms and services for large-scale NGS data processing, which is expected to drive significant market growth in the coming years.


NGS approaches are widely used in genomic research, clinical diagnostics, and precision medicine in oncology, particularly for the diagnosis of breast and lung tumors. Soon, the worldwide NGS data analysis market is predicted to develop due to the rising prevalence of cancer cases around the world. Furthermore, as significant progress is made toward individualized illness therapy, there is a greater demand for fast and precise sequencing interpretation algorithms and tools that can aid in data analysis.


Despite the COVID-19 dilemma, the global market for Next Generation Sequencing (NGS) Data Analysis, which was anticipated to be worth USD 549.2 million in 2020, is expected to expand to USD 1.2 billion by 2026, at a CAGR of 14.1 percent. Services- one of the report's segments, is expected to increase at a 14.9 percent compound annual growth rate to reach USD 814.1 million by the conclusion of the analysis period.


After a careful examination of the pandemic's commercial effects and the resulting economic crisis, the NGS Commercial Software segment's growth is revised to 13 percent CAGR for the next seven years. This sector now controls  44 percent of the global market for Next Generation Sequencing (NGS) Data Analysis.


The increased awareness and expanding demand for sequencing technologies are projected to propel the expansion of analytical software over the next few years. The massive amounts of data created by NGS necessitate management systems and solutions, increasing the demand for algorithms and tools. Companies that lack the infrastructure for data analysis, interpretation, and management are increasingly turning to NGS data analysis services.


 


Weekly Brief

loading
TOP VENDORS
Top 10 Emerging Next Generation Sequencing Companies In Europe- 2022
TOP VENDORS
Top 10 Next-Generation Sequencing Solutions Companies in Europe – 2022
TOP VENDORS
Top 10 Emerging Next Generation Sequencing Companies In Europe- 2022
TOP VENDORS
Top 10 Next-Generation Sequencing Solutions Companies in Europe – 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Antibodies: Immunoglobulin Isotypes

Life Science Consulting Services Trends

Rani Therapeutics and Celltrion Partner to Develop Oral Monoclonal Antibodies

ProPhase Labs Acquires BE-Smart Esophageal Pre-Cancer Screening Test

The Influence of Pharmaceutical Distributors on U.S. Drug Expenditures

Tips to Improve Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/data-analysis-for-nextgeneration-sequencing-worth-usd12-billion-by-2026-cloudbased-platforms-emerging-as-preferred-solutions-nwid-739.html